changing from semaglutide to tirzepatide Switching dose conversion Transitioning Treatments: What to Expect

Begin with a low dose to reduce bloating and gas and gradually increase to the dose that fits your tolerance and goals

While no GLP-1 medication currently carries FDA approval specifically for fatty liver disease, accumulating evidence supports their therapeutic potential through weight loss, improved insulin sensitivity, and reduced systemic inflammation

Thats the standard clinical starting dose used in the SUSTAIN trials and prescribed on the label

PGC-1 upregulation induces NRF1/2 and TFAM expression, supporting mtDNA replication and respiratory chain activity

Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors

Promotes Youthful Skin Tone & Texture*